Skip to main content
Lignes
Carrousel

Laboratoire Radiopharmaceutiques Biocliniques

From the Clinic to the Clinic

 

The LRB research team (Inserm and Université Grenoble Alpes) is a multidisciplinary structure at the heart of Grenoble’s health campus.

 

For over 45 years, our mission has been clear: to design and develop new radiopharmaceuticals [radioactive drugs], to improve the diagnosis, monitoring, and treatment of diseases in Nuclear Medicine, particularly in oncology, cardiology, neurology, and metabolism.

 

Our strength lies in a resolutely translational approach, “from the clinic to the clinic,” driven by a team of about forty researchers, clinicians, pharmacists, and biologists. From the molecular target to clinical trials, every step of development is integrated, with a strong scientific requirement and a steadfast commitment to tomorrow’s medicine.

 

Our technological platform includes radiochemistry laboratories, an imaging laboratory, and an environment certified to ISO 9001 / NF X 50-900 standards, ensuring rigorous scientific standards and traceability.

 

By combining fundamental research, technological innovation, and clinical challenges, we contribute to advancing a more precise, more personalized and deeply human medicine.

Research Themes


Cardiolovascular Diseases

Oncology

 

Metabolic Diseases

Neurodegenerative Diseases

Radiochemistry

Chemistry


New Medical Devices in Cardiology


Publications

In Memoriam

To Gérald Vanzetto 
Read the tribute (in French)

To Anne-Sophie Gauchez
Read the tribute (in French)